Channel
Connected hardware, diagnostics, robotics, wearables and device market/regulatory developments.
The self-disinfecting medical device market is rapidly expanding at a compound annual growth rate of 14%, driven by rising hospital infection rates, a surge in surgical volumes, and increasing healthcare expenditure. This article analyzes market dynamics, key technology trends, and regional competitive landscape.
A study by the American Medical Association shows that most doctors believe data from consumer wearable devices (such as smartwatches) have clinical value, but issues such as accuracy, liability, and data integration still hinder their widespread adoption.
Driven by personalized medicine, regulatory maturity, and declining costs of multi-laser systems, the global additive manufacturing market for medical devices is expected to grow at a compound annual growth rate of 15–20% from 2026 to 2035. Orthopedic implants and surgical guides account for 55–70% of revenue, and in-house 3D printing laboratories in hospitals are accelerating in adoption.
ZS Impact Institute report shows 90% of consumers trust AI health advice as much as that of doctors, early diagnosis could save $500 billion, promoting a zero-distance care model.
MiniMed launches the Abbott-manufactured Instinct continuous glucose monitor in Europe, targeting over 4.5 million Abbott CGM users, aiming to drive insulin pump sales growth through sensor selection.
According to the latest PwC report, the total value of medical technology M&A transactions in the first half of 2026 reached $36.5 billion, led by Boston Scientific's acquisition of Penumbra and Danaher's acquisition of Masimo, indicating that the industry's M&A momentum remains strong.
According to a report by Growth Market Reports, the global capsule endoscopy system market is expected to grow from $1.09 billion in 2024 to $2.15 billion by 2033, at a compound annual growth rate of 8.2%. The rising incidence of gastrointestinal diseases, AI-assisted image analysis, and the demand for non-invasive diagnostics are the key driving factors.
Deloitte's latest research shows that diagnostic manufacturers are shifting from traditional product suppliers to a B2B2C model, with AI, EHR workflow integration, and interoperability becoming key to the next stage of growth.